ARTHRITIS, PSORIATIC

This study follows 200 adults with psoriatic arthritis to see how many continue taking guselkumab for one year. Researchers will track treatment stops, switches, and reasons. The goal is to understand real-world use, not to test a cure.

This study tests a new drug called sonelokimab for adults with active psoriatic arthritis who have not responded well to or cannot tolerate standard TNF-blocker treatments. About 600 participants will receive either sonelokimab, a placebo, or an active reference drug to see if so…

This study tests how well the drug guselkumab improves symptoms of psoriatic arthritis, a condition causing joint pain and skin patches. Researchers will use ultrasound to measure joint inflammation in 200 participants over 24 weeks. The goal is to see if guselkumab reduces swell…

This study tests a new drug, JNJ-88545223, in 240 adults with active psoriatic arthritis (PsA) to see if it reduces joint pain and skin symptoms better than a placebo. Participants receive either the drug or a placebo for 16 weeks, and doctors measure improvements in joint swelli…

This study tests a new drug called icotrokinra (JNJ-77242113) for people with active psoriatic arthritis, a condition causing joint pain and skin patches. About 750 adults who have tried other treatments will receive either the drug or a placebo. The goal is to see if the drug re…

This study tests the safety and effectiveness of guselkumab, a biologic drug, in 100 Indian adults with active psoriatic arthritis who did not get enough relief from standard treatments. Participants receive injections and are monitored for side effects and joint symptom improvem…

This study looks at the long-term safety of a drug called guselkumab in children who have Crohn's disease, ulcerative colitis, or juvenile psoriatic arthritis. About 196 kids who already completed a previous study and benefited from the drug will continue treatment. The main goal…

This study aims to better understand why people with inflammatory arthritis (like rheumatoid or psoriatic arthritis) experience chronic pain. Researchers will follow 350 patients starting new medications to identify different pain types and risk factors. The goal is to pave the w…

This study looks at how natural cannabis compounds (like CBD and THC) affect immune cells from 100 people with chronic inflammatory diseases such as rheumatoid arthritis, lupus, and inflammatory bowel disease. Researchers will take a blood sample and expose the cells to different…